SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001096906-22-000130
Filing Date
2022-01-14
Accepted
2022-01-14 17:10:38
Documents
14
Period of Report
2021-11-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 MYCOTOPIA THERAPIES, INC. - FORM 8-K SEC FILING tpia-20211117.htm   iXBRL 8-K 21053
2 EXECUTIVE CONSULTING AGREEMENT WITH MR. KAPLAN. tpia_ex10z1.htm EX-10.1 89280
  Complete submission text file 0001096906-22-000130.txt   272902

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tpia-20211117_def.xml EX-101.DEF 1809
4 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT tpia-20211117_lab.xml EX-101.LAB 20940
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tpia-20211117_pre.xml EX-101.PRE 13948
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tpia-20211117.xsd EX-101.SCH 33500
8 EXTRACTED XBRL INSTANCE DOCUMENT tpia-20211117_htm.xml XML 2441
Mailing Address 480 22ND STREET HEYBURN ID 83336
Business Address 480 22ND STREET HEYBURN ID 83336 208-677-2020
Mycotopia Therapies, Inc. (Filer) CIK: 0001763329 (see all company filings)

IRS No.: 870645794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56022 | Film No.: 22532626
SIC: 5141 Wholesale-Groceries, General Line
Office of Trade & Services